Skip to content
Trending storyWatching

Fragment-level graph encoding makes molecular property prediction interpretable at functional-group resolution

1 report1 sourceupdated 1 day ago

Start here

Synthesis

A study proposes representing molecules as fragment-level graphs built by BRICS decomposition, so that message-passing graph neural networks and post-hoc attribution methods can explain property predictions at the resolution of functional groups rather than individual atoms. Under scaffold splits, the representation keeps test accuracy comparable to atom-level graphs while shrinking graph size to roughly one-fifth. Attribution quality also improves: Integrated-Gradients hit rates for known pharmacophores of BACE and PTR1 reached 1.5 and 3.2 times the random level, respectively. The work suggests a practical route to models that are both accurate and interpretable for drug-discovery applications, though broader validation on other targets and tasks is still open.

Written by a model from the reports · updated 4 hours ago

Coverage timeline

Follow the coverage to see the different angles.

Oct 21
  1. arxiv.org
    Fragment-Level Graph Encoding for Interpretable Molecular Property Prediction

    The study encodes molecules as fragment-level graphs via BRICS decomposition, so that message-passing GNNs and post-hoc attribution methods explain predictions at functional-group rather than single-atom resolution. Under scaffold splits, this representation maintains comparable test accuracy with graphs roughly five times smaller; Integrated-Gradients hits known pharmacophores at 1.5 times the chance rate for BACE and 3.2 times for PTR1.

Heat trend for this story

Heat now 5·Peak in the comparable set 5 (Oct 22 20:00)·Change over 24h in the comparable set –

0246Oct22Oct22Oct22Oct22

The trend compares only the participants observed in full throughout, so its set can be smaller than the heat figure itself. Move the pointer or click the chart for an hour's heat; the left and right arrow keys work too.

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org